港股异动 | 美国BIO称剔除药明康德会员资格药明合联(02268)、药明康德(02359)均跌超8%

智通财经03-14

智通财经APP获悉，药明系早盘集体大跌，截至发稿，药明合联(02268)跌9.72%，报17.84港元；药明康德(02359)跌8.21%，报46.95港元。消息面上，3月13日晚间，美国知名生物技术组织BIO官网发布一份新闻稿。BIO在新闻稿中表示，将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2419421611?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-14 11:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2419421611","market":"us","top_or_hot":-1,"title":"港股异动 | 美国BIO称剔除药明康德会员资格 药明合联(02268)、药明康德(02359)均跌超8%","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，药明系早盘集体大跌，截至发稿，药明合联(02268)跌9.72%，报17.84港元；药明康德(02359)跌8.21%，报46.95港元。消息面上，3月13日晚间，美国知名生物技术组织BIO官网发布一份新闻稿。BIO在新闻稿中表示，将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1086293.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 美国BIO称剔除药明康德会员资格 药明合联(02268)、药明康德(02359)均跌超8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 美国BIO称剔除药明康德会员资格 药明合联(02268)、药明康德(02359)均跌超8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-14 11:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1086293.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，药明系早盘集体大跌，截至发稿，药明合联(02268)跌9.72%，报17.84港元；药明康德(02359)跌8.21%，报46.95港元。消息面上，3月13日晚间，美国知名生物技术组织BIO官网发布一份新闻稿。BIO在新闻稿中表示，将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1086293.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1086293.html","article_id":"2419421611","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2419421611","pubTimestamp":1710387097,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，药明系早盘集体大跌，截至发稿，药明合联(02268)跌9.72%，报17.84港元；药明康德(02359)跌8.21%，报46.95港元。消息面上，3月13日晚间，美国知名生物技术组织BIO官网发布一份新闻稿。BIO在新闻稿中表示，将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与美国公司合作。药明系此前多次发布澄清公告。3月7日，药明康德、药明生物发布公告，再次否认公司会对美国或其他国家的国家安全构成风险，并会继续关注进展，药明合联则表态，业务持续正常运营。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4121":"生命科学工具和服务","YANG":"三倍做空富时中国ETF-Direxion","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","SG9999014674.SGD":"Nikko AM All China Equity A SGD","BK4588":"碎股","BIO":"Bio Rad实验室","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","YINN":"三倍做多富时中国ETF-Direxion","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","07226":"XL二南方恒科","02268":"药明合联","LU0052750758.USD":"富兰克林中国基金A Acc","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","02359":"药明康德","BK4585":"ETF&股票定投概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK1583":"高瓴概念"},"translate_title":"Hong Kong stocks changed. The US BIO said that excluding WuXi PharmaTech membership, WuXi PharmaTech Union (02268) and WuXi PharmaTech (02359) both fell more than 8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1,"YINN":1,"YANG":1,"02268":1,"07226":1,"BIO":1},"content_text":"智通财经APP获悉，药明系早盘集体大跌，截至发稿，药明合联(02268)跌9.72%，报17.84港元；药明康德(02359)跌8.21%，报46.95港元。消息面上，3月13日晚间，美国知名生物技术组织BIO官网发布一份新闻稿。BIO在新闻稿中表示，将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与美国公司合作。药明系此前多次发布澄清公告。3月7日，药明康德、药明生物发布公告，再次否认公司会对美国或其他国家的国家安全构成风险，并会继续关注进展，药明合联则表态，业务持续正常运营。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2419421611"}

港股异动 | 美国BIO称剔除药明康德会员资格 药明合联(02268)、药明康德(02359)均跌超8%

精彩评论

港股异动 | 美国BIO称剔除药明康德会员资格药明合联(02268)、药明康德(02359)均跌超8%